Point-of-care testing for HCV infection: Recent advances and implications for alternative screening

New Microbiologica

Volumn 37, Issue 4, 2014, Pages 449-457

  Parisi, Maria Rita ^a   Soldini, Laura ^a   Vidoni, Gianmarino ^b   Mabellini, Chiara ^a   Belloni, Teresa ^a   Brignolo, Livia ^b   Negri, Silvia ^c   Schlusnus, Karin ^d   Dorigatti, Fernanda ^a   Lazzarin, Adriano ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Local Public Health Unit   (Italy)

^c ANLAIDS Lombardia Onlus   (Italy)

^d AIRON Communication srl   (Italy)

Author keywords

HCV positive people; HCV prevention; HCV screening test; Saliva oral fluid test

Indexed keywords

HEPATITIS C VIRUS;

HEPATITIS B ANTIBODY;

ADULT; DIAGNOSTIC USE; EPIDEMIOLOGY; EVALUATION STUDY; FEMALE; GENETICS; HEPACIVIRUS; HEPATITIS C; HOSPITAL INFORMATION SYSTEM; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; ITALY; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; PROCEDURES; VIROLOGY; YOUNG ADULT;

ADULT; FEMALE; HEPACIVIRUS; HEPATITIS B ANTIBODIES; HEPATITIS C; HUMANS; ITALY; MALE; MASS SCREENING; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PREVALENCE; YOUNG ADULT;

EID: 84908551408     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bellentani S., Pozzato G., Saccoccio G., Crovatto M., et al. (1999) Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut. 44, 874-880.
2. Center for disease control and prevention. Available from: http://www.cdc.gov/hepatitis/hcv/Management.htm
3. D'Amelio et al. (1995). Low prevalence of anti-HCV antibody among Italian air force recruits. Scand. J. Infect. Dis. 27, 12-14.
4. EASL available at: http://www.easl.eu/
5. EpaC available at: http://www.epac.it/
6. EpaC available at: http://www.epatitec.info/
7. Ferreira-Gonzales A., Shiffman M.L., et al. (2004). Use of diagnostic testing for managing hepatitis C virus infection. Copyright by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA, 9-18.
8. Food and drug administration. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cf-Clia/detail
9. Hoofnagle J.H. (1997) Hepatitis C: the clinical spectrum of disease. Hepatology. 26, 15S-20S.
10. Hutin Y, Kitler M, Dore G, Perz J, Armstrong G, Dusheiko G, et al. (2004) Global burden of disease (GBD) for hepatitis C. J. Clin. Pharmacol. 44, 20-29.
11. ISS available at: www.iss.it
12. Lavanchy D. (2009). The global burden of hepatitis C. Liver. Int. 29, 74-81.
13. OraQuick HCV rapid antibody test. Available from: http://www.fda.gov/MedicalDevices/productsand-MedicalProcedures/DeviceApprovalsandClearances/Recently-approved-Devices
14. OraSure Technologies, Inc. Available from: http://www.orasure.com
15. Parisi M.R., Soldini L., Di Perri G., Tiberi S., Lazzarin A., et al. (2009). Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programs. New Microbiol. 32, 391-396.
16. Parisi M.R., Soldini L., Vidoni G.M., Clemente F., Mabellini C., Belloni T., Nozza S., Brignolo L., Negri S., Rusconi S., Schlusnus K., Dorigatti F., Lazzarin A. (2013). Cross-sectional study of community serostatus to highlight undiagnosed HIV infections with oral fluid HIV-1/2 rapid test in non-conventional settings. New Microbiol. 36, 121-132.
17. Smith B.D., Drobeniuc J., Jewett A., et al. (2011). Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J. Infect. Dis. 204, 825-831.
18. Smith B.D., Teshale E., Jewett A., et al. (2011). Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites. Clin. Infect. Dis. 53, 780-786.
19. Tucker J.D., Bien C.H., Peeling R.W. (2013). Pointof-care testing for sexually transmitted infections: recent advances and implications for disease control. Curr. Opin. Infect. Dis. 26, 73-79.